| |
| | Variagenics Unveils 3-D Display and Analysis System for Genetic Variation Data |
 | | Data to be used in creating molecular diagnostics for predicting efficacy/toxicity of cancer drugs BOSTON, Aug. 15 /PRNewswire/ -- Variagenics, Inc. (Nasdaq: VGNX), a leader in pharmacogenomics, unveiled a new interactive three-dimensional visualization system for individual genetic variations, at the 2001 Drug Discovery Technology Conference. |
 | | Conference delegates were able to navigate from a graphical interface representing the biological pathways targeted by drugs and developmental drug candidates and embark on a tour of the human genome, ultimately arriving at the chromosomal locus for each selected gene. |
 | | The technology, developed by Variagenics in collaboration with Small Design Firm, Inc. of Cambridge, MA, is one of the first applications of this type of interactive graphics to be made available for the biopharmaceutical industry. |
| www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-15-2001/0001555510&EDATE= (613 words) |
|